Joakim Wijkstrom, SVP, Chief Marketing Officer at Vanda Pharmaceuticals Inc. (VNDA), sold 3,605 shares at $10.27 ($37K) on 2022-08-22, disclosed to the SEC on 2022-08-23.
Seasonal sale ($37k) by SVP, Chief Marketing Officer — this insider has traded VNDA in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| VNDA | SELL | 2023-08-23 | $22K | — | Filing → |
| VNDA | SELL | 2023-03-06 | $74K | — | Filing → |
| VNDA | SELL | 2022-03-02 | $156K | — | Filing → |